ArticleScientific reports2026
Cost-effective plant-based medium for enhanced spore production of B. amyloliquefaciens CN12 for biofertilizer application.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this study, endospore-forming bacteria were isolated, screened, and characterized from samples collected in Tan Phu protection forest for potential use in biofertilizer application. Twelve endospore-forming bacteria showed the ability to produce indole-3-acetic acid were evaluated. Based on the relative enzyme activity, siderophore production, phosphate and potassium solubilization, strain CN12 was selected. Strain CN12 was identified as Bacillus amyloliquefaciens based on 16 S rRNA gene sequencing. The liquid culture medium using inexpensive substrates was optimized for increasing its endospore production. The medium consisted of 10% mung bean sprouts extract solution, 0.87% molasses, 0.12% urea, and 0.06% MgSO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.